TB

Tripurari Baranwal

Director Director DIN 03083950
DIN 03083950 First appointment Feb 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2011
Shareholding value Locked Premium profile

About Tripurari Baranwal

Tripurari Baranwal has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 03083950
Primary Designation Director
First Appointment 21 Feb 2011
Oldest Company Age 17 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Dmais Pharmaceuticals Private Limited U85190DL2009PTC187161
Director 21 Feb 2011 2009 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dmais Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tripurari Baranwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tripurari Baranwal

Tripurari Baranwal has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Tripurari Baranwal is associated with 0 companies as Director.

Tripurari Baranwal has expertise in General Business.

Tripurari Baranwal has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available